Immunosuppressants and alloimmunization against red blood cell transfusions

Transfusion

Volumn 54, Issue 8, 2014, Pages 1981-1987

  Zalpuri, Saurabh ^a,b   Evers, Dorothea ^a   Zwaginga, Jaap Jan ^a,b   Schonewille, Henk ^a   De Vooght, Karen M K ^c   Le Cessie, Saskia ^b   Van Der Bom, Johanna G ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; DEXAMETHASONE; ERYTHROCYTE ANTIBODY; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY;

ADULT; AGED; ALLOIMMUNITY; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTILYMPHOCYTE SERUM; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; CASE-CONTROL STUDIES; COMORBIDITY; DRUG SYNERGISM; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ISOANTIBODIES; ISOANTIGENS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 84906265423     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12639     Document Type: Article

References (24)

1. Zalpuri S, Zwaginga JJ, le Cessie S, et al. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012; 102: 144-149.
2. Higgins JM, Sloan SR,. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood 2008; 112: 2546-2553.
3. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006; 46: 1328-1333.
4. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47: 2066-2071.
5. Zalpuri S, Zwaginga JJ, van der Bom JG,. Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study. BMJ Open 2012; 2. pii: e001150.
6. Rothman KJ, Mosquin PL,. Confounding after risk-set sampling in the beryllium study of Sanderson et al. Ann Epidemiol 2011; 21: 773-779.
7. Middelburg RA, Wiersum-Osselton JC, van de Watering LM, et al. Observational etiologic research: part 3-Case-control studies: it's all about the source population. Transfusion 2013; 54: 12-16.
8. Zalpuri S, Schonewille H, Middelburg R, et al. Effect of storage of red blood cells on alloimmunization. Transfusion 2013; 53: 2795-2800.
9. Fishman JA,. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
10. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010; 105: 148-154.
11. van der Kolk LE, Baars JW, Prins MH, et al. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002; 100: 2257-2259.
12. Fauci AS, Dale DC,. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest 1974; 53: 240-246.
13. Fauci AS, Dale DC,. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest 1975; 55: 22-32.
14. Barnes PJ,. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011; 163: 29-43.
15. Elenkov IJ,. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 2004; 1024: 138-146.
16. Lowenberg M, Verhaar AP, van den Brink GR, et al. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol Med 2007; 13: 158-163.
17. Liberman AC, Druker J, Refojo D, et al. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J 2009; 23: 1558-1571.
18. Barshes NR, Goodpastor SE, Goss JA,. Pharmacologic immunosuppression. Front Biosci 2004; 1: 411-420.
19. Gillis S, Crabtree GR, Smith KA,. Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol 1979; 123: 1632-1638.
20. Crabtree GR, Gillis S, Smith KA, et al. Mechanisms of glucocorticoid-induced immunosuppression: inhibitory effects on expression of Fc receptors and production of T-cell growth factor. J Steroid Biochem 1980; 12: 445-449.
21. Crabtree GR, Gillis S, Smith KA, et al. Glucocorticoids and immune responses. Arthritis Rheum 1979; 22: 1246-1256.
22. Larsson EL,. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol 1980; 124: 2828-2833.
23. Ransom JT,. Mechanism of action of mycophenolate mofetil. Ther Drug Monit 1995; 17: 681-684.
24. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61: 85-93.